Chesapeake Energy Corporation (CHK)’s Future Is Brighter Than You Might Think

Page 1 of 2

As used to be said in jest about Elvis, Aubrey McClendon has left the building — figuratively, at least. But since investing is an exercise in attempting to forecast the future, postmortems regarding Chesapeake Energy Corporation (NYSE:CHK)‘s co-founder and longtime CEO’s accomplishments and foibles are now of little value. What’s needed are some answers about the opportunities that may lie ahead for the once-iconic oil and gas producer.

Chesapeake Energy Corporation (NYSE:CHK)Where the company stands
To forge responses, let’s note a few key elements that characterize Chesapeake’s current circumstances:

1). In spite of the difficulties that have befallen the company, it’s crucial to keep in mind that Chesapeake Energy Corporation (NYSE:CHK) essentially set the pattern for discovering, acquiring, and developing acreage in most of the key U.S. unconventional plays. Whether in the Haynesville, Utica, Marcellus, or Eagle Ford shales, the company was among the pioneering operators. As was noted on its post-release call last week, it continues to have a “tremendous asset base.”

2). Natural gas prices continue to sit at a relatively paltry $3.45 per British thermal unit. As such, management is working feverishly to increase liquids production, especially oil. In 2011 liquids constituted 17% of total output; for 2012, that share rose to 30%.

3). Acreage acquisitions and drilling programs are costly, and so Chesapeake’s balance sheet has groaned in recent years under inappropriately high debt levels. The company’s new regime is trimming its drilling and attempting to sell assets in order to strengthen the capital structure. On Monday it was announced that China Petroleum & Chemical Corp (ADR) (NYSE:SNP)’s Sinopec would pay $1.02 billion for half of Chesapeake’s Mississippi Lime properties in Oklahoma.

4). At a $20.50 Friday close, Chesapeake’s shares are now trading at about 70% below their five-year high.

No slouch as an operator
Having covered those key elements at the company, let’s glance at its current operations. In the Eagle Ford of South Texas, for instance (where total production from all operators grew by a whopping 68% year over year in December), Chesapeake, in partnership with China’s CNOOC Limited (ADR) (NYSE:CEO), grew its liquids production by 32% in 2012. The partnership’s land position in the hot play is second only to that of Houston-based independent producer EOG Resources, Inc. (NYSE:EOG). In the most recent quarter, Chesapeake connected 98 Eagle Ford wells, and management expects to hook up another 400 this year.

In the vast Utica Shale, which literally lies beneath the Marcellus Shale in several of the nation’s northeastern states — and extends from Canada into northeastern Tennessee — Chesapeake has long been the leader of the pack. Working In concert with France’s TOTAL S.A. (ADR) (NYSE:TOT), it holds a position in the big play in excess of 450,000 net acres. To date, the company has drilled 184 wells in the Utica, of which 45 are currently producing.

And as is the case in the Eagle Ford, it’s significant that the company has achieved a meaningful boost to its operating efficiencies in the Utica. Its drilling cycle times there were down 37% year over year in 2012, and its drilling and completion costs dropped by fully 27%.

Buy, sell, or ignore?
So should we take a flier on Chesapeake shares? Before you respond, let’s note the key question mark affecting the company today, and likely well into the future. I’m referring, of course, to the moribund prices being paid for plentiful, clean-burning U.S. natural gas.

The future price of gas could move higher or remain relatively flat. The difference will depend on progress that is or isn’t made toward using the fuel widely in domestic transportation, the degree of zealousness exhibited by the Environmental Protection Agency and environmentalists in opposing fracking, and the success of those same environmentalists and a corporate contingent in blocking LNG production and exports.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!